Related Experiment Video
Updated: Jan 14, 2026

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
19.4K
Self-Supervised Based Multi-View Graph Presentation Learning for Drug-Drug Interaction Prediction.
1Department of Computer Science, New Jersey Institute of Technology, Newark, NJ 07102, USA.
Summary
This study introduces Self-Supervised Multi-View Graph Representation Learning (SMG-DDI) to predict drug-drug interactions (DDIs). SMG-DDI effectively uses unlabeled molecular data, outperforming current methods for DDI prediction.
Area of Science:
- Computational chemistry
- Bioinformatics
- Machine learning in drug discovery
Background:
- Drug-drug interactions (DDIs) pose significant risks in polypharmacy, necessitating accurate prediction methods.
- Existing hierarchical graph representation learning for DDIs faces limitations due to scarce experimental data and potential overfitting with supervised methods.
- Supervised models fail to utilize vast unlabeled public molecular datasets, hindering performance.
Purpose of the Study:
- To develop a novel multi-view graph representation learning method, SMG-DDI, for enhanced drug-drug interaction prediction.
- To overcome the data scarcity bottleneck in DDI prediction by leveraging unlabeled molecular datasets.
- To improve the accuracy and generalizability of DDI prediction models.
Main Methods:
- Proposed Self-Supervised Multi-View Graph Representation Learning (SMG-DDI) for DDI prediction.
- Utilized a pre-trained Graph Convolutional Network (GCN) for inter-view molecule graph representation learning (atoms as nodes, bonds as edges).
- Captured intra-view molecular interactions and generated drug embeddings for final DDI prediction.
Main Results:
- SMG-DDI demonstrated superior performance compared to state-of-the-art DDI prediction methods across various dataset scales.
- Achieved prediction accuracies of 0.83, 0.79, and 0.73 on small, medium, and large test datasets, respectively.
- Validated that molecular structure information significantly aids in predicting potential drug-drug interactions.
Conclusions:
- SMG-DDI effectively addresses data limitations in DDI prediction by incorporating self-supervised learning and multi-view graph representations.
- The proposed method offers a promising approach for accurate and reliable prediction of drug-drug interactions.
- Leveraging unlabeled molecular data through advanced graph representation learning enhances DDI prediction capabilities.
Related Concept Videos
Drug-Receptor Interactions
7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
Pharmacokinetics: Drug–Drug Interactions
349
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
349
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Drug-Receptor Interaction: Antagonist
4.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
4.8K
Combined Effects of Drugs: Antagonism
11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Quantitative Aspects of Drug-Receptor Interaction
1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K

